The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of disease-free survival as surrogate endpoint for overall survival using two individual patient data meta-analyses of adjuvant chemotherapy in operable non-small cell lung cancer.
S. Michiels
Disclosure not yet available
A. Mauguen
Disclosure not yet available
D. Fisher
Disclosure not yet available
S. Burdett
Disclosure not yet available
R. Paulus
Disclosure not yet available
S. J. Mandrekar
Disclosure not yet available
C. P. Belani
Disclosure not yet available
F. A. Shepherd
Disclosure not yet available
T. Eisen
Disclosure not yet available
H. Pang
Disclosure not yet available
L. Collette
Disclosure not yet available
C. Le Pechoux
Disclosure not yet available
J. Pignon
Disclosure not yet available